8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
Pooled results from many studies on one question.
2023 / Systematic review of prospective studies
A systematic review evaluated 17 prospective studies from PubMed and Web of Science examining the association between ultra-processed food (UPF) consumption and incident obesity and cardiometabolic risk factors. Eight studies assessed general and abdominal obesity, one assessed impaired fasting blood glucose, four examined diabetes, two examined dyslipidemia, and one examined metabolic syndrome. Substantial agreement emerged linking UPF consumption with the incident risk of general and abdominal obesity, and most studies reported associations with increased risk of hypertension, diabetes, and dyslipidemia. The authors note that evidence on cardiometabolic risk was more limited and further longitudinal studies considering diet quality and changes over time are needed.
Shows an association, not proof of cause and effect.
Mambrini SP, Menichetti F, Ravella S, et al. Nutrients, 2023. PMID 37299546
2023 / Systematic review and meta-analysis of prospective observational studies
A systematic review and meta-analysis evaluated 76 prospective observational publications with 2,230,443 adults to assess plant-based dietary patterns and chronic disease risk. Higher adherence to plant-based patterns was inversely associated with type 2 diabetes (RR 0.82 [95% CI: 0.77-0.86]), CVD (0.90 [0.85-0.94]), cancer (0.91 [0.87-0.96]), and all-cause mortality (0.84 [0.78-0.92]), though with moderate to high heterogeneity (I2: 47.8-95.4%). When emphasizing healthy plant foods, inverse associations strengthened for diabetes (0.79 [0.72-0.87]), CVD (0.85 [0.80-0.92]), and cancer (0.86 [0.80-0.92]). Conversely, unhealthy plant-based diets were positively associated with these disease outcomes.
Shows an association, not proof of cause and effect.
Wang Y, Liu B, Han H, et al. Nutr J, 2023. PMID 37789346
2023 / Umbrella review of meta-analyses
An umbrella review searched six databases to evaluate the link between vegetarian diets and cardiovascular and cerebrovascular outcomes. Findings showed risk reductions of 41.2% for cerebrovascular disease, 29% for CVD incidence, 13.8% for CVD mortality, and 24.1% for IHD incidence (with high heterogeneity). Significant reductions were also observed for IHD mortality (32.1%), ischemic stroke (32.9%), and stroke incidence (39.1% in a single study), while stroke mortality had a non-significant 11.6% reduction with moderate heterogeneity. The authors noted that evidence quality and consistency varied.
Shows an association, not proof of cause and effect.
Ocagli H, Berti G, Rango D, et al. Nutrients, 2023. PMID 37836394
2023 / Systematic review and dose-response meta-analysis of RCTs
A systematic review and meta-analysis of 13 RCTs evaluated the effects of purslane consumption on lipid profiles and C-reactive protein (CRP). Compared to the control group, purslane consumption significantly reduced serum triglycerides (WMD: -16.72, 95% CI: -22.49, -10.96 mg/dL, p < .001), total cholesterol (WMD: -9.97, 95% CI: -19.86, -0.07 mg/dL, p = .048), and CRP (WMD: -1.22, 95% CI: -1.63, -0.80 mg/L, p < .001). It also significantly increased HDL-C (WMD: 4.09, 95% CI: 1.77, 6.41 mg/dL, p = .001), while LDL-C levels were not affected. According to a suggested optimal dosage, purslane consumption is considered to be safe up to 30 g/day.
Jafari N, Bahreini N, Dehghani A, et al. Food Sci Nutr, 2023. PMID 37970383
2023 / Systematic review and meta-analysis
A systematic review and meta-analysis of 18 research articles evaluated the dose-response relationship between ultra-processed food (UPF) consumption and noncommunicable diseases. UPF consumption significantly increased daily intake of carbohydrates (49.64%), added sugar (40.78%), saturated fat (30.00%), sodium (27.76%), energy (26.67%), cholesterol (25.69%), and total fat (15.77%), while fiber intake was -38.55% below recommendations. Each 10% increase in UPF intake was significantly linked to higher risks of diabetes (HR ± 95% CI: 1.115 ± 0.044), cardiovascular diseases (1.096 ± 0.053), obesity (1.068 ± 0.050), and cancer (1.020 ± 0.020).
Shows an association, not proof of cause and effect.
Bestari FF, Andarwulan N, Palupi E Foods, 2023. PMID 38137261
2023 / Systematic review and meta-analysis of randomized trials
A meta-analysis evaluated four randomized trials (N = 227) examining Emblica officinalis aqueous fruit extract versus placebo over 12 weeks in adults with dyslipidemia. The extract significantly decreased total cholesterol (SMD = -21.23 mg/dL, 95% CI: -34.22 to -8.25; P = 0.001) and LDL-C (SMD = -25.12 mg/dL, 95% CI: -40.24 to -10.00; P = 0.001), and increased HDL-C (SMD = 4.74 mg/dL, 95% CI: 0.40 to 9.07; P = 0.03). No statistically significant difference was seen in serum triglycerides (SMD = -22.28 mg/dL, 95% CI: -53.33 to 8.76; P = 0.16). High heterogeneity was present across all lipid outcomes (I2 between 72% and 93%), and findings were based on low certainty of evidence.
Acampado LRT, Chiu HHC, Larrazabal RB, et al. Acta Med Philipp, 2023. PMID 39678212
2022 / Systematic review and dose-response meta-analysis of prospective cohort studies
A systematic review and dose-response meta-analysis of prospective cohort studies examined the relationship of milk and dairy intake with mortality risk. High-fat milk consumption was significantly associated with a greater risk of all-cause (Pooled ES: 1.15; 95% CI: 1.09-1.20), CVD (Pooled ES: 1.09; 95% CI: 1.02-1.16), and cancer mortality (Pooled ES: 1.17; 95% CI: 1.08-1.28). Conversely, total dairy consumption was linked to a lower risk of CVD mortality (Pooled ES: 0.93; 95% CI: 0.88-0.98), showing a significant non-linear association with all-cause and CVD mortality. High-fat milk intake was also significantly associated with cancer mortality risk in both linear and non-linear dose-response analyses.
Shows an association, not proof of cause and effect.
Naghshi S, Sadeghi O, Larijani B, et al. Crit Rev Food Sci Nutr, 2022. PMID 33397132
2022 / Systematic review and meta-analysis of prospective cohort studies
A systematic review and meta-analysis of 12 prospective cohort studies examined adherence to plant-based diets and mortality risk in 508,861 participants. The highest versus lowest category of adherence to plant-based diets had a hazard ratio of 0.90 (95% CI: 0.82, 0.99) for all-cause mortality and 0.77 (95% CI: 0.70, 0.86) for CHD mortality. All-cause mortality was also inversely associated with healthy plant-based (HR 0.92; 95% CI: 0.88, 0.96), Pesco-vegetarian (HR 0.81; 95% CI: 0.70, 0.92), and Pro-vegetarian (HR 0.74; 95% CI: 0.55, 0.88) diets. Vegetarian diets were associated with lower cardiovascular mortality (HR 0.92; 95% CI: 0.85, 0.99) and CHD mortality (HR 0.76; 95% CI: 0.68, 0.85). The authors noted limitations in some included studies, warranting further research.
Shows an association, not proof of cause and effect.
Jafari S, Hezaveh E, Jalilpiran Y, et al. Crit Rev Food Sci Nutr, 2022. PMID 33951994
2022 / Systematic review of interventional trials
A systematic review of 84 interventional trials (RCTs and non-randomized trials lasting at least 4 weeks) evaluated the efficacy of plant-predominant diets for treating obesity and cardiometabolic sequelae. In general, plant-based diets demonstrated improved weight control, lipids, cardiovascular end points, blood pressure, insulin sensitivity, A1C, fasting glucose, and a lower risk of diabetes compared with usual diets and in some cases standard health-oriented diets. Preliminary studies suggested that plant-predominant diets within healthy lifestyle interventions may stabilize or even reverse type 2 diabetes and cardiovascular disease. Acceptability and sustainability were generally similar to other health-oriented diets.
Remde A, DeTurk SN, Almardini A, et al. Nutr Rev, 2022. PMID 34498070
2022 / Systematic review and meta-analysis
A systematic review and meta-analysis of 7 clinical and 27 preclinical studies evaluated the effect of Arthrospira (Spirulina) on glycemic and lipid markers. In clinical studies, Arthrospira significantly reduced fasting blood sugar (MD -1.77, 95% CI -2.90 to -0.63), total cholesterol (MD -2.54, 95% CI -4.61 to -0.46), and triglycerides (MD -3.71, 95% CI -6.54 to -0.89), while increasing HDL-C (MD 2.27, 95% CI 0.67 to 3.86). However, it did not significantly reduce HbA1c (MD -0.59, 95% CI -2.23 to 1.04) or LDL-C in humans. Subgroup analyses showed significant FBS reductions with doses under 2 grams [-3.22 (-5.67, -0.76)] and durations under 2 months [-2.52 (-4.37, -0.67)].
Ghanbari F, Amerizadeh A, Behshood P, et al. Curr Probl Cardiol, 2022. PMID 34538515
2022 / Systematic review and meta-analysis of RCTs
A systematic review and meta-analysis evaluated five randomized controlled trials including 1049 participants with metabolic syndrome to assess the effects of synbiotic interventions. Synbiotic supplementation significantly reduced serum insulin (WMD -6.39 μU/mL), triglycerides (WMD -20.3 mg/dl), total cholesterol (WMD -7.8 mg/dl), LDL cholesterol (WMD -9.02 mg/dl), waist circumference (WMD -4.04 cm), body weight (WMD -4.3 kg), systolic blood pressure (WMD -1.8 mmHg), and IL-6 (WMD -0.2 pg/mL), while increasing HDL cholesterol (WMD 2.3 mg/dl). No significant effects were observed for fasting plasma glucose, HOMA-IR, BMI, diastolic blood pressure, heart rate, or C-reactive protein.
Arabi SM, Bahrami LS, Rahnama I, et al. Pharmacol Res, 2022. PMID 34999222
2022 / Dose-response meta-analysis of prospective cohort studies
A dose-response meta-analysis of 19 prospective cohort studies evaluated the link between egg intake and mortality in 1,737,893 participants. An increase of 1 egg/day was associated with pooled hazard ratios of 1.08 (95% CI, 1.01-1.15) for all-cause mortality, 1.07 (95% CI, 0.97-1.18) for cardiovascular disease mortality, and 1.16 (95% CI, 1.04-1.30) for cancer mortality. Nonlinear dose-response associations were identified for all three mortality outcomes. The positive association with all-cause mortality was more pronounced in studies adjusting for blood cholesterol-related covariates (Pinteraction = 0.011), though the overall certainty of evidence was rated as very low.
Shows an association, not proof of cause and effect.
Yang PF, Wang CR, Hao FB, et al. Nutr Rev, 2022. PMID 35178575
2022 / Meta-analysis of clinical studies
A meta-analysis of 40 articles (14,750 cases) evaluated the effects of NAD+ precursors (NR, NMN, NA, and NAM) on lipid and glucose metabolism. NAD+ precursor supplementation significantly reduced TG (SMD = -0.35, P < 0.0001), TC (SMD = -0.33, P = 0.0005), and LDL (SMD = -0.38, P < 0.00001), while increasing HDL (SMD = 0.66, P < 0.00001) and plasma glucose (SMD = 0.27, P = 0.0004). Subgroup analyses indicated nicotinic acid (NA) had the most significant effects on these markers, with significant benefits seen in patients with cardiovascular disease and dyslipidemia but little effect in healthy people. The authors note the conclusions are limited by the number and quality of included studies.
Zhong O, Wang J, Tan Y, et al. Nutr Metab (Lond), 2022. PMID 35303905
2022 / Systematic review and dose-response meta-analysis of RCTs
A systematic review and meta-analysis of 10 randomized controlled trials evaluated the effects of Chlorella vulgaris supplementation on lipid profiles in 539 adults. Supplementation led to significant reductions in total cholesterol (MD -7.47 mg/dL, 95% CI: -12.98 to -1.96) and LDL-C (MD -7.71 mg/dL, 95% CI: -14.05 to -1.37), but had no significant effect on triglycerides (MD -2.11 mg/dL, 95% CI: -7.28 to 3.06) or HDL-C (MD -0.45 mg/dL, 95% CI: -0.67 to 1.57). Dose-response analysis revealed the LDL-C-reducing effect occurred at dosages between 0 and 1500 mg/d (P for non-linearity = 0.01), with no significant effect at higher amounts. Only four of the 10 trials had low risk of bias across all Cochrane domains, and only two verified the content, purity, potency, and contamination of the supplements.
Sherafati N, Bideshki MV, Behzadi M, et al. Complement Ther Med, 2022. PMID 35331862
2022 / Systematic review and dose-response meta-analysis of cohort studies
Researchers conducted a systematic review and dose-response meta-analysis of 33 cohort studies including 2,216,720 participants and 232,408 all-cause deaths to evaluate egg intake and mortality risk. Comparing the highest versus lowest egg intake categories showed no association with all-cause mortality (RR: 1.02; 95% CI: 0.94, 1.11), CVD (RR: 1.04; 95% CI: 0.87, 1.23), CHD (RR: 0.98; 95% CI: 0.84, 1.16), stroke (RR: 0.81; 95% CI: 0.64, 1.02), or respiratory disease mortality (RR: 0.96; 95% CI: 0.53, 1.71), but was associated with higher cancer mortality (RR: 1.20; 95% CI: 1.04, 1.39). In linear dose-response analyses, each additional egg per week was linked to a 2% and 4% increased risk of all-cause and cancer mortality, respectively, and a 4% decreased risk of stroke mortality. The certainty of the evidence was rated as low to moderate.
Shows an association, not proof of cause and effect.
Mousavi SM, Zargarzadeh N, Rigi S, et al. Adv Nutr, 2022. PMID 35396834
2022 / Systematic review and dose-response meta-analysis
Researchers conducted a meta-analysis of 24 articles with 48 reports (11,890,695 participants) to examine egg intake and mortality risks. Each 1-egg/day increase was associated with a higher risk of all-cause mortality (RR: 1.06; 95% CI: 1.02, 1.10; P = 0.008), though this was restricted to women, Americans, and studies adjusting for hyperlipidemia. A linear association with CVD mortality appeared only in adults >60 years, Americans, studies with ≥15 years follow-up, and those adjusting for hyperlipidemia (P ≤ 0.018). No significant associations were observed for ischemic heart disease or stroke mortality (P ≥ 0.080).
Shows an association, not proof of cause and effect.
Ma W, Zhang Y, Pan L, et al. J Nutr, 2022. PMID 35524693
2022 / Systematic review and meta-analysis
A systematic review and meta-analysis evaluated the effects of voluntary slow breathing (VSB) on heart rate variability (HRV) parameters indexing parasympathetic nervous system activity regulating cardiac functioning (vmHRV). From 1,842 selected abstracts, 223 studies were included (172 assessing effects during the session, 16 immediately after one session, and 49 after a multi-session intervention). Results showed increases in vmHRV during VSB, immediately after one session, and after a multi-session intervention.
Laborde S, Allen MS, Borges U, et al. Neurosci Biobehav Rev, 2022. PMID 35623448
2022 / Systematic review and dose-response meta-analysis
A meta-analysis of 55 prospective cohort studies evaluated the relationship between egg and dietary cholesterol intake and mortality. Each additional egg per day was associated with a 7% higher risk of all-cause mortality (RR 1.07, 95% CI: 1.02-1.12) and a 13% higher risk of cancer mortality (RR 1.13, 95% CI: 1.06-1.20), but not CVD mortality (RR 1.00, 95% CI: 0.92-1.09). Each 100 mg/day increment of dietary cholesterol was linked to a 6% higher risk of all-cause mortality (RR 1.06, 95% CI: 1.03-1.08) and cancer mortality (RR 1.06, 95% CI: 1.05-1.07), but not CVD mortality. Little evidence for elevated risks appeared below 0.5 egg/day or 250 mg/day of cholesterol; the authors note findings should be considered with caution due to small risk estimates and moderate between-study heterogeneity.
Shows an association, not proof of cause and effect.
Darooghegi Mofrad M, Naghshi S, Lotfi K, et al. Front Nutr, 2022. PMID 35711545
2022 / Random effects network meta-analysis of randomized trials
A network meta-analysis assessed the comparative efficacy of various lipid-lowering nutraceuticals across 131 trials with 13,062 participants. Except for policosanols, all evaluated nutraceuticals reduced LDL-C (-1.21 to -0.17 mmol/l) and TC (-1.75 to -0.18 mmol/l) compared with placebo or no intervention. Bergamot and red yeast rice were the most effective for lowering LDL-C (-1.21 mmol/l [-46.8 mg/dl] and -0.94 mmol/l [-36.4 mg/dl], respectively) and TC. The authors noted that evidence for bergamot was based on a relatively small study group and requires further investigation.
Osadnik T, Goławski M, Lewandowski P, et al. Pharmacol Res, 2022. PMID 35988871
2022 / Umbrella review of systematic reviews and meta-analyses
An umbrella review analyzed 89 articles on nut and seed consumption and health outcomes, including 23 meta-analyses on disease and mortality and 66 on biomarkers. Eating 28 g/d of nuts compared with not eating nuts was associated with a 21% relative risk reduction in cardiovascular disease, an 11% reduction in cancer deaths, and a 22% reduction in all-cause mortality. Nut intake was also inversely associated with mortality from respiratory diseases, infectious diseases, and diabetes, though associations with diabetes incidence were mixed. Allergy and adverse reactions were reported in 1-2% of adult populations with substantial heterogeneity.
Shows an association, not proof of cause and effect.
Balakrishna R, Bjørnerud T, Bemanian M, et al. Adv Nutr, 2022. PMID 36041171
2022 / Umbrella meta-analysis of clinical trials
An umbrella meta-analysis of 19 articles evaluated the effect of curcumin supplementation on lipid profile parameters in adults using a random-effects model. Curcumin supplementation was effective in reducing total cholesterol (ES = -0.81 mg/dl; 95% CI: 1.39, -0.24, p = 0.006), triglycerides (ES: 0.84 mg/dl, 95% CI: 1.42, -0.27, p = 0.004), and LDL-C (ES: 0.49 mg/dl, 95% CI: 0.85, -0.13, p = 0.007). In addition, curcumin intake significantly increased HDL-C levels (ES: 1.34 mg/dl, 95% CI: 0.37, 2.31, p = 0.007).
Musazadeh V, Roshanravan N, Mohammadizadeh M, et al. Nutr Metab Cardiovasc Dis, 2022. PMID 36058763
2022 / Systematic review and meta-analysis
A systematic review and meta-analysis of 17 studies evaluated stroke risk across vegetarian, low-animal, and high-animal diets over an average follow-up of 11.7 years. Compared to low use, high use of vegetarian and low-animal diets was associated with lower risks of hemorrhagic stroke (RR: 0.71 and 0.82), ischemic stroke (RR: 0.78 and 0.70), and total stroke (RR: 0.84 and 0.72), respectively. High use of a high-animal diet was associated with a relatively higher risk of stroke (RR: 1.12 [95% CI: 0.94, 1.29]). Among vegetarians, high fruit intake relative to high vegetable intake was linked to a lower stroke risk.
Shows an association, not proof of cause and effect.
Liu Y, Zhu L, Li D, et al. Asia Pac J Clin Nutr, 2022. PMID 36173214
2022 / Systematic review and meta-analysis
A systematic review and meta-analysis evaluated the effects of high-fructose corn syrup (HFCS) versus sucrose across 4 articles with 767 participants, where sweetener usage averaged 19% of daily caloric intake. Compared to sucrose, HFCS intake did not significantly change weight (WMD: -0.29 kg, 95% CI: -1.34 to 0.77, I2 = 0%), waist circumference, BMI, fat mass, TC, HDL, LDL, TG, SBP, or DBP. However, data from three studies showed a significant increase in CRP levels in the HFCS group compared to sucrose (WMD: 0.27 mg/l, 95% CI: 0.02 to 0.52, I2 = 23%).
Li X, Luan Y, Li Y, et al. Front Nutr, 2022. PMID 36238453
2022 / Systematic review and meta-analysis of randomized controlled trials
A systematic review and meta-analysis of 14 randomized controlled trials evaluated the effects of oral bergamot supplementation on adult lipid profiles using a random-effects model. Bergamot supplementation significantly reduced total cholesterol (WMD: -63.60 mg/dL; 95% CI: -78.03 to -49.18; p < .001), triglycerides (WMD: -74.72 mg/dL; 95% CI: -83.58 to -65.87; p < .001), and LDL-C (WMD: -55.43 mg/dL; 95% CI: -67.26 to -43.60; p < .001), while significantly increasing HDL-C (WMD: 5.78 mg/dL; 95% CI: 3.27 to 8.28; p < .001). However, findings regarding nutraceuticals containing bergamot were inconsistent, and the authors noted that higher-quality studies are needed to further establish clinical efficacy.
Sadeghi-Dehsahraei H, Esmaeili Gouvarchin Ghaleh H, Mirnejad R, et al. Phytother Res, 2022. PMID 36251526